StockNews.com Begins Coverage on Avinger (NASDAQ:AVGR)

Stock analysts at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

Shares of AVGR stock opened at $0.60 on Wednesday. Avinger has a fifty-two week low of $0.39 and a fifty-two week high of $5.45. The stock’s fifty day moving average price is $0.74 and its two-hundred day moving average price is $0.97. The company has a market cap of $1.99 million, a PE ratio of -0.05 and a beta of 1.15.

Avinger (NASDAQ:AVGR) last released its quarterly earnings data on Thursday, November 7th. The medical device company reported ($1.82) earnings per share for the quarter, beating the consensus estimate of ($2.03) by $0.21. Avinger had a negative return on equity of 5,527.11% and a negative net margin of 261.06%. The business had revenue of $1.65 million for the quarter, compared to analyst estimates of $1.60 million. During the same period last year, the firm posted ($2.92) earnings per share. On average, equities analysts predict that Avinger will post -4.69 EPS for the current fiscal year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.